Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Avon Lake, OH
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Avon Lake, OH
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Canton, OH
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Garfield Heights, OH
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Tulsa, OK
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Charleston, SC
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Charleston, SC
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Memphis, TN
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
DeSoto, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
DeSoto, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Lake Jackson, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Katy, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Katy, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Wharton, TX
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Wharton, TX
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Charlottesville, VA
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Bothell, WA
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated:  7/18/2013
Clinical Research Facility
mi
from
Kirkland, WA
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)
Status: Enrolling
Updated: 7/18/2013
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
CNRI-San Diego
mi
from
San Diego, CA
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
CNRI-San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
Comprehensive Clinical Development
mi
from
Washington,
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
Comprehensive Clinical Development
mi
from
Washington,
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
Community Clinical Research
mi
from
Austin, TX
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Neurocognitive Model of Anorexia Nervosa
A Neurocognitive Model of Anorexia Nervosa
Status: Enrolling
Updated:  7/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
A Neurocognitive Model of Anorexia Nervosa
A Neurocognitive Model of Anorexia Nervosa
Status: Enrolling
Updated: 7/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
San Diego Sexual Medicine
mi
from
San Diego, CA
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Meridien Research
mi
from
Bradenton, FL
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Compass Research LLC
mi
from
Orlando, FL
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Meridien Research
mi
from
St Petersburg, FL
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Meridien Research
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Annapolis Sexual Wellness Center
mi
from
Annapolis, MD
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Annapolis Sexual Wellness Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Maryland Prime Care Physicians
mi
from
Stevensville, MD
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Maryland Prime Care Physicians
mi
from
Stevensville, MD
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
Center for Sexual Medicine at Sheppard Pratt
mi
from
Townson, MD
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
Center for Sexual Medicine at Sheppard Pratt
mi
from
Townson, MD
Click here to add this to my saved trials
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated:  7/29/2013
NECCR of Fall River
mi
from
Fall River, MA
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms
Status: Enrolling
Updated: 7/29/2013
NECCR of Fall River
mi
from
Fall River, MA
Click here to add this to my saved trials
Maternal, Adiposity, Metabolism, and Stress Study
Maternal, Adiposity, Metabolism, and Stress Study (MAMAS)
Status: Enrolling
Updated:  8/1/2013
University of California - San Francisco
mi
from
San Francisco, CA
Maternal, Adiposity, Metabolism, and Stress Study
Maternal, Adiposity, Metabolism, and Stress Study (MAMAS)
Status: Enrolling
Updated: 8/1/2013
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 023
mi
from
Glendale, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 023
mi
from
Glendale, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 005
mi
from
Riverside, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 005
mi
from
Riverside, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 004
mi
from
Long Beach, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 004
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 007
mi
from
San Diego, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 016
mi
from
San Diego, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 016
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 012
mi
from
Cerritos, CA
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 012
mi
from
Cerritos, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative site 017
mi
from
Fort Lauderdale, FL
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative site 017
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site #015
mi
from
Fort Myers, FL
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site
mi
from
Kissimmee, FL
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 20
mi
from
Doral, FL
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 20
mi
from
Doral, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  8/1/2013
Forest Investigative Site 15
mi
from
Leesburg, FL
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Forest Investigative Site 15
mi
from
Leesburg, FL
Click here to add this to my saved trials